Shares of Novo Nordisk climbed 4.5% on Wednesday after the Danish pharmaceutical giant reported a stronger-than-expected fourth-quarter net profit, driven by soaring demand for its obesity treatment, Wegovy. However, the company warned that sales growth could slow in 2025 as competition intensifies in the weight-loss drug market. Net profit for…
Shares of British pharmaceutical giant GSK surged on Wednesday after the company raised its long-term sales forecast and reported…
Bitcoin is in focus this week after President Trump announced plans to set up a US sovereign fund aimed…
Estée Lauder, a name synonymous with luxury and beauty for nearly eight decades, is facing a critical moment. The…
Indian Finance Minister Nirmala Sitharaman raised the income tax exemption limit from 0.7 million to 1.2 million rupees as she announced…
US President Donald Trump has signed an executive order directing the creation of a US sovereign wealth fund, with…
China’s Finance Ministry announced the imposition of 15% tariffs on coal and liquefied natural gas imports from the US,…
With Mexico buying itself reprieve from Trump’s tariffs, all eyes are on the outcome of Canada’s dialogue with the…
The US has signed agreements with both Mexico and Canada to delay the implementation of its planned tariffs on…